Daniel Carey is the director of the Good Laboratory Practice (GLP) quality assurance (QA), scientific support and GLP/Good Clinical Practice (GCP) archiving solutions. With Quality Assurance Consultancy for more than 25 years, he is currently responsible for the overall management and direction of the group and previously served as a senior consultant, archivist and radiation safety officer. His 30-year past and current professional experience covers all aspects of QA work under the Food and Drug Administration (FDA), Environmental Protection Agency (EPA) and Organisation for Economic Co-operation and Development (OECD) Good Laboratory Practice (GLP) regulations, plus FDA/International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Good Clinical Practices (GCP). Additionally, Mr. Carey has a thorough understanding and proven track record of all study types (mammalian toxicology, ecotoxicology, biotechnology, analytical/bio-analytical chemistry, field trials, etc.) for regulatory submission. His GCP experience involves his work with contract research organizations (CROs) and as principal investigator (PI) for site qualification audits, study site audits, database audits, report audits, etc.
Prior to joining Quality Assurance Consultancy, Mr. Carey led a team of approximately 50 scientists and administrative personnel as the laboratory manager at Biospherics Inc., a well-recognized CRO. In this capacity, he was responsible for ensuring the laboratory provided analytical services to the pesticide industry as well as federal and state government agencies and various private companies.
Mr. Carey holds a bachelor’s degree from the University of Maryland.
